课题基金 / 基金详情

SEQUENTIAL PRE AND POSTNATAL GENE THERAPY OF HEMOPHILIA

SEQUENTIAL PRE AND POSTNATAL GENE THERAPY OF HEMOPHILIA
血友病产前和产后序贯基因治疗
批准号：
6527413
负责人：
KARIN L GAENSLER
金额：
$28.2万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-09-01 至 2004-08-31
来源：
https://reporter.nih.gov/project-details/6527413
关键词：
age difference blood coagulation disorders coagulation factor IX coagulation factor VIII embryo /fetus therapy enzyme linked immunosorbent assay gene therapy hemophilia As hemophilia B immune tolerance /unresponsiveness laboratory mouse nonhuman therapy evaluation transfection /expression vector

项目成果

KARIN L GAENSLER的其他基金

相关文献

期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Efficacy and safety of novel CD80 IL15 IL15Ra expressing autologous AML vaccines
Efficacy and safety of novel CD80 IL15 IL15Ra expressing autologous AML vaccines
Lentivirus-based positive/negative selection in minimally ablative transplants
Lentivirus-based positive/negative selection in minimally ablative transplants